Gyre Therapeutics Ratios (2010-2026) | GYRE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Profitability
Gross Margin (Quarter)	-0.35%	-2.16%	-0.50%			96.06%	95.49%	96.33%	96.30%	95.40%	96.40%	96.95%	96.24%	95.78%	95.95%	95.70%	94.67%	95.31%	94.55%	92.41%
EBT Margin (Quarter)	-1,205.48%	-873.98%	-1,830.73%			-22.46%	25.15%	19.96%	34.92%	-369.38%	45.93%	23.92%	15.42%	2.77%	21.01%	8.36%	24.96%	-0.18%	-41.02%	-49.59%
EBIT Margin (Quarter)	-1,097.39%	-845.67%	-1,851.51%			-22.13%	26.73%	16.96%	39.84%	-337.53%	29.70%	12.66%	16.61%	2.39%	10.30%	8.11%	22.66%	0.32%	-41.54%	-49.35%
EBITDA Margin (Quarter)	-1,097.39%	-845.67%	-1,851.51%			-22.13%	26.73%	16.96%	39.84%	-337.53%	29.70%	12.66%	16.61%	2.39%	10.30%	8.11%	22.66%	0.32%	-41.54%	-49.35%
Operating Margin (Quarter)	-1,097.39%	-845.67%	-1,851.51%			-22.13%	26.73%	16.96%	39.84%	-337.53%	29.70%	12.66%	16.61%	2.39%	10.30%	8.11%	22.66%	0.32%	-41.54%	-49.35%
Net Margin (Quarter)	-1,097.78%	-873.98%	-1,830.73%			-29.47%	9.00%	6.32%	12.41%	-372.06%	27.72%	13.99%	4.41%	-0.36%	12.23%	1.65%	11.81%	-4.63%	-38.59%	-40.07%
FCF Margin (Quarter)	-960.94%	-735.89%	-1,517.63%			41.67%	34.80%	7.01%	17.50%	3.82%	9.76%	-27.55%	4.05%	-9.66%	-1.14%	7.00%	12.86%	-15.42%	13.42%	-58.44%
Efficiency
Inventory Average (Quarter)											4.61M	5.29M	6.01M	6.36M	7.11M	8.37M	8.86M	9.51M	10.76M	11.39M
Assets Average (Quarter)	90.16M	67.10M	47.97M	61.82M	57.20M	57.89M	51.75M	15.57M	11.18M	63.25M	119.27M	121.47M	123.08M	125.32M	127.60M	141.22M	156.01M	162.76M	164.07M	180.63M
Invested Capital (Quarter)
Asset Utilization Ratio (Quarter)	0.08	0.11	0.14	0.09	0.06	1.77	2.44	10.00	16.80	1.79	0.97	0.92	0.85	0.84	0.79	0.72	0.69	0.72	0.71	0.66
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-10.19	-30.59	-29.28	35.81	-861.00	24.82	10.36	-12.44	105.49	-438.43	25.62	1.53	2.22	2.76	3.58	1.49	5.72	0.46	-11.08	-3.35
Debt Ratio (Quarter)
Times Interest Earned (Quarter)	-10.19	-30.59	-29.28	35.81	-861.00	24.82	10.36	-12.44	105.49	-438.43	25.62	1.53	2.22	2.76	3.58	1.49	5.72	0.46	-11.08	-3.35
Dividends & Payouts
FCF Payout Ratio (Quarter)							0.89	1.70	0.27
Valuation
Enterprise Value (Quarter)	-69.87M	-46.85M	-34.82M	-75.39M	-23.09M	29.70M	-8.10M	-11.53M	-2.23M	19.20M	15.88M	7.89M	10.17M	8.43M	17.69M	-16.96M	-24.51M	-4.03M	-14.12M	-22.84M
Return Ratios
Return on Sales (Quarter)	-0.12%	-0.09%	-0.18%	-0.02%	0.04%	0.00%	0.00%	0.00%	0.00%	-0.04%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	-118.53%	-166.04%	-230.48%	-15.15%	20.43%	20.16%	68.07%	-125.11%	20.67%	-155.61%	-65.96%	-63.84%	-70.25%	15.28%	9.54%	7.52%	8.59%	7.95%	-0.10%	-10.97%
Return on Invested Capital (Quarter)
Return on Assets (Quarter)	-0.01%	-0.01%	-0.02%	0.00%	0.00%	0.00%	0.00%	-0.02%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Datasets

Plans

Developers

Gyre Therapeutics Ratios (2010-2026) | GYRE

Research Tools

Datasets

Plans

Developers

Gyre Therapeutics Ratios (2010-2026) | GYRE

Create an account

Sign In

Reset Password